Fogorvosi szemle, 2007 (100. évfolyam, 1-6. szám)

2007-10-01 / 5. szám

230

FOGORVOSI SZEMLE

100. évf. 5. sz. 2007.

and root surface conditioning - and experimental study in dogs. Biomaterials 2004; 25: 1831-1840.

61. Nemcowsky CE, Zahavi S, Moses O, Kebudi E, Artzi Z, Beny L, Weinreb M: Effect of enamel matrix protein derivative on healing of surgical supra-infrabony periodontal defects in the rat molar: a histomorphometric study: J Periodontol 2006; 77: 996-1002.

62. Sallum EA, Casati MZ, Caffesse RG, Funis LP, Nociti Junior FH, Sallum AW: Coronally positioned flap with or without enamel matrix protein derivative for the treatment of gingival recessions. Am J Dent 2003; 16: 287-291.

63. Sallum EA, Pimentel SP, Saldanha JB, Nogueira-Filho GR, Casati MZ, Nociti FH, Sallum AW: Enamel matrix derivative and guided tissue regeneration in the treatment of dehiscence-type defects: a histomorphometric study in dogs. J Periodontol 2004; 75: 1357- 1363.

64. Cochran DL,KingGN,SchoolfieldJ,Velasquez-plataD,MellonigJT, Jones A: The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses. J Periodontol 2003; 74: 1043-1055.

65. Regazzini PF, Novaes AB Jr, de Oliveira PT, Palioto DB, Taba M Jr, de Souza SL, Grisi MF: Comparative study of enamel matrix derivative with or without GTR in the treatment of class I furcation lesions I dogs. Int J Periodontics Restorative Dent 2004; 24: 476-487.

66. Donos N, Sculean A, Glavind L, Reich E, Karring T: Wound healing of degree III furcation involvements following guided tissue regeneration and/or Emdogain. A histologic study. J Clin Periodontol2003; 30: 1061-1068.

67. Heul L: Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997; 24: 693-696.

68. Yukna RA, Mellonig J: Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000; 71: 752-759.

69. Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E: Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodont Res 1999; 34: 310-322.

70. Mellonig JT: Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999; 19: 9-19.

71. Sculean A, Chiantella GC, Windisch P, Donos N: Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain®). Int J Periodont Rest Dent 2000; 20: 375-381.

72. Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G: Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: a human case report. Int J Periodontics Restorative Dent 2005; 25: 283-294.

73. Rasperini G, Silvestri M, Schenk RK, Nevins ML: Clinical and histological evaluation of human gingival recession treated with a subepithelial connective tissue graft and enamel matrix derivative (Emdogain): a case report. Int J Periodontics Restorative Dent 2000; 20: 269-275.

74. Carnio J, Camargo PM, Kenney EB, Schenk RK: Histological evaluation of 4 cases of root coverage following a connective tissue graft combined with an enamel matrix derivative preparation. J Periodontol 2002; 73: 1534-1543.

75. McGuire MK, Cochran DL: Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 2: Histological evaluation. J Periodontol2003; 74: 1126-1135.

76. Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS: Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Invest 2002; 6: 183-187.

77. Sculean A, Junker R, Donos N, Windisch P, Brecx M, Dünker N: Immunohistochemical evaluation of matrix molecules associated with wound healing following treatment with an enamel matrix protein derivative in humans. Clin Oral Invest 2003; 7: 167-174.

78. Sculean A, Berakdar M, Windisch P, Remberger K, Donos N, Brecx M: Immunohistochemical investigation on the pattern of vimentin expression in regenerated and intact monkey and human periodontal ligamemt. Arch Oral Biol 2003; 2003; 48: 77-86.

79. Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP: Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodont Res 2005; 40: 158-167.

80. Bosshardt DD, Sculean A, Donos N, Lang NP: Pattern of mineralization after periodontal tissue engineering with enamel matrix proteins. Eur J Oral Sei 2006; 114 (Suppl. 1 ): 225-231.

81. St. George G, Darbar U, Thomas G: Inflammatory external root resorption following surgical treatment for intra-bony defects: a report of two cases involving Emdogain® and a review of the literature. J Clin Periodontol 2006; 33: 449-454.

82. Sculean A, Windisch P, Keglevich T, Gera I: Histologic evaluation of human intrabony defects followin' non-surgical periodontal therapy with and without application of an enamel matrix protein derivative. J Periodontol 2003; 74: 153-160.

83. Wennström JL, Lindhe J: Some effects of enamel matrix proteins on wound healing in the dento-qinqival region. J Clin Periodontol 2002; 29: 9-14.

84. Hagenaars S, Louwerse PH, Timmerman MF, Van der Velden U, Van der Weijden GA: Soft-tissue wound healing following periodontal surgery and Emdogain application. J Clin Periodontol 2004; 31: 850-856.

85. Okuda K, Miyazaki A, Momose M, Murata M, Nomura T, Kubota T, Wolff LF, Yosie H: Levels of tissue inhibitor of metalloproteinases- 1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). J Periodont Res 2001 ; 36: 309-316.

86. Gutierrez MA, Mellonig JT, Cochran DL: Evaluation of enamel matrix derivative as an adjunct to non-surgical periodontal therapy. J Clin Periodontol 2003; 30: 739-745.

87. Mombelli A, Brochut P, Plagnat D, Casagni F, Giannopoulou C: Enamel matrix proteins and systemic antibiotics as adjuncts to nonsurgical periodontal treatment: clinical effects. J Clin Periodontol 2005; 32: 225-230.

88. Petinaki E, Nikolopoulos S, Castanas E: Low stimulation of peripheral lymphocytes, following in vitro application of Emdogain. J Clin Periodontol 1998; 25: 715-720.

89. Nikolopoulos S, Petinaki E, Castanas E: Immunologic effects of Emdogain in humans: one-year results. Int J Periodont Rest Dent 2002; 22: 269-277.

90. Zetterstr0mO,AnderssonC,ErikssonL, FrederikssonA.FriskoppJ, Heden G, Janssson B, Lundgren T, Nilveus R, Olsson A, Renvert S, Salonen L, Sjöström L, Winell A, Östgren A, Gestrelius S: Clinical safety of enamel matrix derivative (Emdogain®) in the treatment of periodontal defects. J Clin Periodontol 1997; 24: 697-704.

91. Froum S, Weinberg M, Novak J, Mailhot J, Mellonig J, Van Dyke T, McClain P, Papapanou PN, Childers G, Ciancio S, Blieden T, Polson A, Greenstein G, Yukna R, Wallace ML, Patters M, Wagener C: A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two intrabony defects. J Periodontol 2004; 75: 1001-1008.

92. Heul L, Heden G, SvardstrOm G, Östgren A: Enamel matrix derivative (Emdogain®) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24: 705-714.

93. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D: A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12- month re-entry study. J Periodontol 2001 ; 72: 25-34.

94. Pontoriero R, Wennström J, Lindhe J: The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999; 26: 833-840.

95. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B: Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 2002; 29: 317- 325.

96. Rösing CK, Aass AM, Mavropoulos A, Gjermo P: Clinical and ra